Q4 2021 Heidelberg Pharma AG Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining Heidelberg Pharma's conference call to discuss 2021 fiscal year results and provide a business update. (Operator Instructions) Please note that today's call is being recorded. (Operator Instructions)
I would now like to turn the call over to Dr. Jan Schmidt-Brand, CEO and CFO. Please go ahead, Jan.
Thank you, Regina. Hello, ladies and gentlemen, and welcome to the Heidelberg Pharma conference call to discuss our 2021 fiscal year results and to provide the business update.
My name is Jan Schmidt-Brand, and I am CEO and CFO of the company. Joining me on the call today is my colleague, Professor Andreas Pahl, Chief Scientific Officer; and Katja Arnold, our Investor Relations consultant.
Today, we try a new conference call setting. We now combine presentation, audio and video, and we hope this will be more convenient for our audience. Please note that this presentation is available
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |